These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20211320)

  • 1. Comparison of evidence-based versus non-evidence-based pharmacotherapy on the risk of cardiovascular hospitalization and all-cause mortality among patients with established cardiovascular disease.
    Nichols GA; Wang F; Pedula KL
    Am J Cardiol; 2010 Mar; 105(6):786-91. PubMed ID: 20211320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
    Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
    Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication underuse during long-term follow-up in patients with peripheral arterial disease.
    Hoeks SE; Scholte op Reimer WJ; van Gestel YR; Schouten O; Lenzen MJ; Flu WJ; van Kuijk JP; Latour C; Bax JJ; van Urk H; Poldermans D
    Circ Cardiovasc Qual Outcomes; 2009 Jul; 2(4):338-43. PubMed ID: 20031859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical care costs among patients with established cardiovascular disease.
    Nichols GA; Bell TJ; Pedula KL; O'Keeffe-Rosetti M
    Am J Manag Care; 2010 Mar; 16(3):e86-e93. PubMed ID: 20205493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
    Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
    Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of age on the use of evidence-based therapies for acute myocardial infarction.
    Tran CT; Laupacis A; Mamdani MM; Tu JV
    Am Heart J; 2004 Nov; 148(5):834-41. PubMed ID: 15523314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in sex-based mortality difference with implementation of new cardiology guidelines.
    Novack V; Cutlip DE; Jotkowitz A; Lieberman N; Porath A
    Am J Med; 2008 Jul; 121(7):597-603.e1. PubMed ID: 18538296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
    Ezekowitz J; McAlister FA; Humphries KH; Norris CM; Tonelli M; Ghali WA; Knudtson ML;
    J Am Coll Cardiol; 2004 Oct; 44(8):1587-92. PubMed ID: 15489090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a multifactorial intervention on mortality in type 2 diabetes.
    Gaede P; Lund-Andersen H; Parving HH; Pedersen O
    N Engl J Med; 2008 Feb; 358(6):580-91. PubMed ID: 18256393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy.
    Tsang JL; Mendelsohn A; Tan MK; Hackam DG; Leiter LA; Fitchett D; Lin PJ; Grima E; Langer A; Goodman SG;
    Am J Cardiol; 2008 Nov; 102(9):1142-5. PubMed ID: 18940280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
    Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
    J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of evidence-based therapy for the prevention of cardiovascular events among older people.
    Castelino RL; Chen TF; Guddattu V; Bajorek BV
    Eval Health Prof; 2010 Sep; 33(3):276-301. PubMed ID: 20801973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.